1st Hatchling in Captivity Offers Hope for Cambodia's Endangered Black Marsh Turtle

Turtle keeper Phorn Sreymom, 42, measures a baby Black Marsh Turtle, which was successfully hatched for the first time in Cambodia from turtles rescued from a black market seller, to check its health and growth at the Angkor Centre for Conservation of Biodiversity (ACCB), in Siem Reap province, Cambodia, July 16, 2024. REUTERS/Chantha Lach
Turtle keeper Phorn Sreymom, 42, measures a baby Black Marsh Turtle, which was successfully hatched for the first time in Cambodia from turtles rescued from a black market seller, to check its health and growth at the Angkor Centre for Conservation of Biodiversity (ACCB), in Siem Reap province, Cambodia, July 16, 2024. REUTERS/Chantha Lach
TT

1st Hatchling in Captivity Offers Hope for Cambodia's Endangered Black Marsh Turtle

Turtle keeper Phorn Sreymom, 42, measures a baby Black Marsh Turtle, which was successfully hatched for the first time in Cambodia from turtles rescued from a black market seller, to check its health and growth at the Angkor Centre for Conservation of Biodiversity (ACCB), in Siem Reap province, Cambodia, July 16, 2024. REUTERS/Chantha Lach
Turtle keeper Phorn Sreymom, 42, measures a baby Black Marsh Turtle, which was successfully hatched for the first time in Cambodia from turtles rescued from a black market seller, to check its health and growth at the Angkor Centre for Conservation of Biodiversity (ACCB), in Siem Reap province, Cambodia, July 16, 2024. REUTERS/Chantha Lach

The first Black Marsh Turtle hatched in captivity in Cambodia is being carefully nurtured by conservationists until it can be released back into the wild as part of a plan to rebuild the population of the endangered reptile.
The baby turtle hatched in late May at the Angkor Centre for Conservation of Biodiversity (ACCB), after its parents were rescued from the black market, Reuters reported.
The tiny reptile, just 6 cm long and weighing around 40 grams, is expected to stay in the sanctuary until it is big enough to be less vulnerable to its natural predators, ACCB country director Christel Griffioen said.
"Once we get there, and it might take four-to-six years, we will then look at re-introducing this individual, or bringing this animal back to the wild," Griffioen said.
At that point, she said she hopes that trackers can be used to follow the turtle to "learn more about the ecology of the species and our plans for long term re-introduction and recovering of the species in Cambodia.”
The Black Marsh Turtle, a freshwater reptile native to Southeast Asia, is listed as endangered by the International Union for Conservation of Nature (IUCN). Adults typically grow to around 17-20 cm.
The population is under threat from loss of habitat and the illegal wildlife trade, sought after for both its meat and for its shell, which is used in traditional medicines.
The ACCB, based in Siem Reap province, which is also home to the Angkor Wat temple complex, currently has six adult Black Marsh Turtles and also houses 29 other endangered species.



King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
TT

King Fahd Medical City, Boston Oncology Sign MoU for Localization of Gene and Target Cell Therapy

The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj. SPA

Saudi Arabia’s King Fahd Medical City and Boston Oncology have signed a Memorandum of Understanding (MoU) for a project to localize gene and target cell therapy.

The project will be held at King Fahd Medical City, one of the components of the Riyadh Second Health Cluster, the Saudi Press Agency (SPA) reported Monday.
The MoU was signed by King Fahd Medical City Chief Executive Officer Dr. Fahad AlGhofaili and Boston Oncology Chief Executive Director Dr. Abdullah Bajaaj.

The Saudi Deputy Minister for Planning and Development Eng. Abdulaziz Al-Rumaih attended the signing ceremony at the Saudi Ministry of Health.

AlGhofaili affirmed that the MoU aligns with the Medical City's plans towards the objectives of the Saudi Transformation Program in Healthcare Sector, which contributes to the enhancement of advanced healthcare services provided through the localization of modern techniques in treatment.

"The localization of therapeutic technology in the Kingdom is one of our main goals, which aligns with the Saudi Vision 2030 regarding health transformation programs,” SPA quoted AlGhofaili as saying.

“Therefore, we seek to develop local capabilities in the field of advanced medical treatment and technologies by enhancing cooperation with national and international institutions,” he added.